imSAVAR is a project receiving funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement No . This Joint Undertaking receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA.
The Fraunhofer Institute for Interfacial Engineering and Biotechnology IGB is project partner and responsible for hosting and maintaining the project website.
The Fraunhofer Institute for Interfacial Engineering and Biotechnology IGB
(Fraunhofer-Institut für Grenzflächen-und Bioverfahrenstechnik IGB)
is a constituent entity of the Fraunhofer-Gesellschaft, and as such has no separate legal status.
Imprint of Fraunhofer-Gesellschaft
We used font awesome icons on this website:
Credit and copyright notices: